Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Heal

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Neuropharmacology|December 1, 1985
Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptorsD J Heal, J Philpot, S G Molyneux, et al.
European Journal of Pharmacology|January 16, 1998
Weak blockade of AMPA receptor-mediated depolarisations in the rat cortical wedge by phenytoin but not lamotrigine or carbamazepineI Phillips, K F Martin, K S Thompson, et al.
Psychopharmacology Bulletin|January 1, 1996
Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profileP L Needham, J Atkinson, M J Skill, et al.
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Antidepressant treatments, including electroconvulsive shock and the putative antidepressant sibutramine hydrochloride, do not alter [3H]-prazosin binding to rat cortical membranesK F Martin, I Phillips, D J Heal, et al.
Psychopharmacology|January 1, 1986
The influence of central noradrenergic function on 5-HT2-mediated head-twitch responses in mice: possible implications for the actions of antidepressant drugsD J Heal, J Philpot, K M O'Shaughnessy, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1995
Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatmentsK F Martin, I Phillips, S C Cheetham, et al.
European Journal of Pharmacology|November 5, 1981
Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodentsD J Heal, H Akagi, J M Bowdler, et al.
Brain Research|July 17, 1998
GABA-evoked depolarisations in the rat cortical wedge: involvement of GABAA receptors and HCO3- ionsI Phillips, K F Martin, K S Thompson, et al.
Neuropharmacology|December 18, 2022
Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicinesD J Heal, J Gosden, S L Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitorC Gundlah, K F Martin, D J Heal, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Neuropharmacology|December 1, 1985
Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptorsD J Heal, J Philpot, S G Molyneux, et al.
European Journal of Pharmacology|January 16, 1998
Weak blockade of AMPA receptor-mediated depolarisations in the rat cortical wedge by phenytoin but not lamotrigine or carbamazepineI Phillips, K F Martin, K S Thompson, et al.
Psychopharmacology Bulletin|January 1, 1996
Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profileP L Needham, J Atkinson, M J Skill, et al.
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Antidepressant treatments, including electroconvulsive shock and the putative antidepressant sibutramine hydrochloride, do not alter [3H]-prazosin binding to rat cortical membranesK F Martin, I Phillips, D J Heal, et al.
Psychopharmacology|January 1, 1986
The influence of central noradrenergic function on 5-HT2-mediated head-twitch responses in mice: possible implications for the actions of antidepressant drugsD J Heal, J Philpot, K M O'Shaughnessy, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1995
Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatmentsK F Martin, I Phillips, S C Cheetham, et al.
European Journal of Pharmacology|November 5, 1981
Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodentsD J Heal, H Akagi, J M Bowdler, et al.
Brain Research|July 17, 1998
GABA-evoked depolarisations in the rat cortical wedge: involvement of GABAA receptors and HCO3- ionsI Phillips, K F Martin, K S Thompson, et al.
Neuropharmacology|December 18, 2022
Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicinesD J Heal, J Gosden, S L Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitorC Gundlah, K F Martin, D J Heal, et al.
Pageof 10